Wyeth Beats Profit Forecast; Raises 2007 Outlook

Thursday, 19 Jul 2007 | 7:54 AM ET

Wyeth reported higher-than-expected second-quarter earnings Thursday on strong sales growth of its prescription drugs, and it raised its profit forecast for the year.

The drug maker said it earned $1.2 billion, or 87 cents per share, up from $1.06 billion, or 78 cents per share, a year earlier.

Excluding special items, Wyeth earned 90 cents per share. Analysts on average had expected 87 cents, according to Reuters Estimates.

Wyeth's revenue rose 10% in the quarter to $5.65 billion, above Wall Street expectations of $5.48 billion. It would have risen only 7% if not for positive foreign exchange factors.

Global revenue from prescription drugs grew 11% to $4.75 billion, fueled by sales of the company's Prevnar vaccine to prevent childhood infections caused by pneumococcal bacteria, ulcer drug Protonix and Enbrel for arthritis.

Sales of consumer health products, including Centrum vitamins and Advil painkiller, rose 4% to $623 million, while revenue from the company's animal health products rose 2% to $279 million.

In view of favorable financial trends, Wyeth raised its full-year profit forecast, excluding special items, to between $3.48 per share and $3.56 per share. It had previously projected $3.40 to $3.50.

The updated forecast translates into profit growth of 10.8% to 13.3%, compared with last year.


Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Bitcoin. Digital gold rush or a shadowy tool empowering criminals on the dark web? What is really driving The Bitcoin Uprising? CNBC's Mary Thompson takes an in-depth look at this emerging digital currency by speaking to the bitcoin faithful, who believe the open source currency will upend the global financial system, as well as those who believe bitcoin is an easily manipulated tool that empowers criminals, hackers and drug barons in the dark online underworld. Although the future of bitcoin is uncertain, The Bitcoin Uprising sheds much needed light on the speculative currency and the future of money.

  • Loyalists around the world have embraced it as the cryptocurrency of the future, but some big names on the street differ widely in their beliefs about bitcoin. The Oracle of Omaha thinks it's a "joke." Tech entrepreneur Marc Andreessen counters that Buffett is out of touch, while bitcoin believers like Jonathan Rumion fully embrace the digital currency by buying groceries with bitcoin and even getting paid in bitcoin. CNBC's Mary Thompson reports.

  • Authorities say the online black-market bazaar Silk Road could be the tip of the iceberg when it comes to the criminal underworld using bitcoin for trading in illicit goods and services. On the "Dark Web," fake IDs, drugs, even hit men are all paid in bitcoin. CNBC's Mary Thompson explores why bitcoin is the currency of choice for criminal activity on the dark web and reports on the story of Mt. Gox, the largest bitcoin exchange, which shut down in February, leaving bitcoin investors holding the bag.